Evidence map›Paper›PMID 34469717›Full record

ArticleCell reports2021

Intra- and extra-cellular environments contribute to the fate of HIV-1 infection.

Sneha Ratnapriya, Miranda Harris, Angela Chov, Zachary T Herbert, Vladimir Vrbanac, Maud Deruaz, Vasudevan Achuthan, Alan N Engelman, Joseph Sodroski, Alon Herschhorn

Open access · goldAbstract readComparative Study
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Incompletely closed HIV-1Npj viruses · 2025
    Article
  5. Article
  6. mRNA-based HIV-1 vaccines.Clinical microbiology reviews · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Alternative substitutions of N332 in HIV-1bioRxiv : the preprint server for biology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sneha RatnapriyaDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Miranda HarrisDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Angela ChovDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Zachary T HerbertMolecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Vladimir VrbanacHumanized Immune System Mouse Program, Ragon Institute of MGH, MIT and Harvard, and Center for Immunology and Inflammatory Disease, Cambridge, MA 02139, USA.
Maud DeruazHumanized Immune System Mouse Program, Ragon Institute of MGH, MIT and Harvard, and Center for Immunology and Inflammatory Disease, Cambridge, MA 02139, USA.
Vasudevan AchuthanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Alan N EngelmanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Joseph SodroskiDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
Alon HerschhornDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: aherschh@umn.edu.
University of Minnesota · USDana-Farber Cancer Institute · USHarvard University · USRagon Institute of MGH, MIT and Harvard · US

Funding

Nuclear Localization of HIV-1 Preintegration ComplexesR01AI052014 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 2003 to 2025
$11.4M
Biochemical Mechanism of HIV DNA IntegrationR37AI039394 · NIAID · DANA-FARBER CANCER INST · PI Alan N. Engelman · 2010 to 2026
$10.2M
NIAID NIH HHS R01 AI052014NIAID NIH HHS R37 AI039394
6 · The paper itself

Abstract

HIV-1 entry into host cells leads to one of the following three alternative fates: (1) HIV-1 elimination by restriction factors, (2) establishment of HIV-1 latency, or (3) active viral replication in target cells. Here, we report the development of an improved system for monitoring HIV-1 fate at single-cell and population levels and show the diverse applications of this system to study specific aspects of HIV-1 fate in different cell types and under different environments. An analysis of the transcriptome of infected, primary CD4+ T cells that support alternative fates of HIV-1 identifies differential gene expression signatures in these cells. Small molecules are able to selectively target cells that support viral replication with no significant effect on viral latency. In addition, HIV-1 fate varies in different tissues following infection of humanized mice in vivo. Altogether, these studies indicate that intra- and extra-cellular environments contribute to the fate of HIV-1 infection.

Indexed as

Cellular MicroenvironmentAnimalsAnti-HIV AgentsCD4-Positive T-LymphocytesDisease Models, AnimalFemaleGene Expression RegulationHEK293 CellsHIV-1HIV InfectionsHost-Pathogen InteractionsHumansMiceMice, Inbred NODMice, SCIDTHP-1 CellsAnti-HIV AgentsHIV-1 fateHIV-1 latencyhumanized mouse modeltranscriptomic analysis

Identifiers

PMID34469717
PMCPMC8463096
OpenAlexW3198577512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.